You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rvx000222

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

Completed
  • Dyslipidemia
  • +3 more
  • RVX000222
  • Placebo
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Nov 1, 2022

Fabry Disease Trial in Halifax (RVX000222)

Unknown status
  • Fabry Disease
  • RVX000222
  • Halifax, Nova Scotia, Canada
    Queen Elizabeth II Health Sciences Centre, Victoria General Site
Mar 25, 2019

Atherosclerosis, Coronary Artery Disease Trial in Tustin (RVX000222, Placebo)

Completed
  • Atherosclerosis
  • Coronary Artery Disease
  • RVX000222
  • Placebo
  • Tustin, California
    Orange County Research Center
Jul 20, 2016

Dyslipidemia, Coronary Artery Disease Trial in Adelaide (RVX000222, Rosuvastatin, Atorvastatin)

Terminated
  • Dyslipidemia
  • Coronary Artery Disease
  • RVX000222
  • +2 more
  • Adelaide, South Australia, Australia
    Royal Adelaide Hospital / CMAX
May 8, 2015

Diabetes Trial in Melbourne (RVX000222, Placebo, RVX000222)

Completed
  • Diabetes
  • RVX000222
  • Placebo, RVX000222
  • Melbourne, Victoria, Australia
    Baker IDI Heart and Diabetes Institute 75 Commercial Road,
Mar 31, 2014

Coronary Artery Disease Trial in Worldwide (RVX000222, Placebo RVX000222)

Completed
  • Coronary Artery Disease
  • RVX000222
  • Placebo RVX000222
  • La Plata, Buenos Aires, Argentina
  • +57 more
Jun 3, 2013

Coronary Artery Disease, Dyslipidemia Trial in South Africa (RVX000222, Placebo RVX000222)

Completed
  • Coronary Artery Disease
  • Dyslipidemia
  • RVX000222
  • Placebo RVX000222
  • East Burger Street, Bloemfontein, South Africa
  • +24 more
Sep 19, 2012